Takayuki Ohwada
Fukushima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Vascular composition data supporting the role of N-3 polyunsaturated fatty acids in the prevention of cardiovascular disease events.
Journal: Data in brief
Published: December 11, 2015
STENTING STRATEGY AND FOLLOW-UP RESULTS OF MULTI-CENTER REGISTRY IN FUKUSHIMA CITY FOR LEFT MAIN CORONARY ARTERY DISEASE: BARE METAL STENT VERSUS DRUG-ELUTING STENT.
Journal: Fukushima journal of medical science
Published: July 03, 2015
Vasopressin V2 receptor antagonist tolvaptan is effective in heart failure patients with reduced left ventricular systolic function and low blood pressure.
Journal: International heart journal
Published: March 06, 2015
Long-term effects and prognosis in acute heart failure treated with tolvaptan: the AVCMA trial.
Journal: BioMed research international
Published: May 13, 2014
Acute heart failure volume control multicenter randomized (AVCMA) trial: comparison of tolvaptan and carperitide.
Journal: Journal of clinical pharmacology
Published: April 25, 2013
Importance of multi-detector computed tomography for percutaneous coronary intervention in a patient with type V dual left anterior descending artery.
Journal: Journal of cardiology cases
Published: February 27, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026